Fucoidan extracted from Fucus evanescens prevents endotoxin-induced damage in a mouse model of endotoxemia

Marine Drugs

Volumn 12, Issue 2, 2014, Pages 886-898

  Kuznetsova, Tatyana A ^a   Besednova, Natalya N ^a   Somova, Larisa M ^a   Plekhova, Natalya G ^a  

^a Institute of Epidemiology and Microbiology   (Russian Federation)

Author keywords

Cytokines; Endotoxin; Fucoidans; Hemostasis; Immunity; Lipopolysaccharides; Sulfated polysaccharide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; FUCOIDIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ISOLATION; ENDOTOXEMIA; FUCUS; FUCUS EVANESCENS; HISTOPATHOLOGY; HYPERCOAGULABILITY; IMMUNOMODULATION; MICROANGIOPATHY; MOUSE; MOUSE MODEL; NONHUMAN; PROTEIN BLOOD LEVEL; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ENDOTOXINS; FUCUS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MICROCIRCULATION; POLYSACCHARIDES; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896716830     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md12020886     Document Type: Article

References (34)

1. Berteau, O.; Mulloy, B. Sulfated fucans, fresh perspectives: Structures, functions, and biological priperties of sulfated fucans and overview of enzymes active toward this class of polysaccharide. Glycobiology 2003, 13, 29-40.
2. Cumashi, A.; Ushakova, N.; Preobrazhenskaya, M.; D'Incecco, A.; Piccoli, A.; Totani, L.; Tinari, N. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007, 17, 541-552.
3. Li, B.; Lu, F.; Wei, X.; Zhao, R. Fucoidan: Structure and Bioactivity. Molecules 2008, 13, 1671-1695.
4. Jiao, G.; Yu, G.; Zhang, J.; Ewart, H. Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar. Drugs 2011, 9, 196-223.
5. Wijesekara, I.; Pangestuti, R.; Kim, S. Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae. Carbohydr. Polym. 2011, 84, 14-21.
6. Jeong, B.E.; Ko, E.J.; Joo, H.G. Cytoprotective effects of fucoidan, an algae-derived polysaccharide on 5-fluorouracil-treated dendritic cells. Food Chem. Toxicol. 2012, 50, 1480-1484.
7. Vishchuk, O.S.; Ermakova, S.P.; Zvyagintseva, T.N. The Effect of Sulfated (1→3)-α-L-Fucan from the Brown Alga Saccharina cichorioides Miyabe on Resveratrol-Induced Apoptosis in Colon Carcinoma Cells. Mar. Drugs 2013, 11, 194-212.
8. Costa, L.S.; Fidelis, G.P.; Telles, C.B. Antioxidant and Antiproliferative Activities of Heterofucans from the Seaweed Sargassum filipendula. Mar. Drugs 2011, 9, 952-966.
9. Opal, S.M. Endotoxins and Other Sepsis Triggers. Contrib. Nephrol. 2010, 167, 14-24.
10. Enukidze, G.; Anikhovskaya, I.; Marachev, A.; Yakovlev, M. Endotoxin aggression in the pathogenesis of chronic inflammatory diseases of small pelvis organs and infertility, or an antiendotoxin approach to their treatment. Hum. Physiol. 2006, 32, 351-356.
11. Yakovlev, M. Endotoxin aggression as premorbidity or universal factor of the pathogenesis of human and animal. Biol. Bull. Rev. 2003, 123, 31-40.
12. Meshkov, M.V.; Anikhovskaia, I.A.; Urazaev R.A.; Iakovlev, M.I. Endotoxin aggression in the development of hemostatic disorders in children with surgical diseases. Khirurgiia 2006, 3, 32-37.
13. Eun-Ju, K.; Hong-Gu, J. Fucoidan Enhances the Survival and Sustains the Number of Splenic Dendritic Cells in Mouse Endotoxemia. Korean J. Physiol. Pharmacol. 2011, 15, 89-94.
14. Kuznetsova, T.A.; Besednova, N.N.; Mamaev, A.N.; Momot, A.P.; Shevchenko, N.M.; Zvyagintseva, T.N. Anticoagulant activity of fucoidan from brown algae of the Okhotsk Sea Fucus evanescens. Bull. Exp. Biol. Med. 2003, 136, 53-59.
15. Zaporozhets, T.S.; Kuznetsova, T.A.; Smolina, T.P.; Shevchenko, N.M.; Zvyagintseva, T.N.; Besednova, N.N. Immunotropic and anticoagulant properties of fucoidan from brown algae Fucus evanescens: Prospects of application in medicine. J. Microbiol. 2006, 3, 54-58.
16. Khil'chenko, S.R.; Zaporozhets, T.S.; Shevchenko, N.M.; Zvyagintseva, T.N.; Vogel, U.; Seeberger, P.; Lepenies, B. Immunostimulatory Activity of Fucoidan from the Brown Alga Fucus evanescens: Role of Sulfates and Acetates. J. Carbohydr. Chem. 2011, 30, 291-305.
17. Makarenkova, I.D.; Akhmatova, N.K.; Semenova, I.B.; Zvyagintseva, T.N.; Besednova, N.N. Effect of fucoidan from brown algae on the maturation of dendritic cells generated from peripheral blood monocytes in vitro. Russ. J. Immunol. 2012, 6, 105-106.
18. Hack, C.E.; Poll, T.; Thijs, L.G. Sepsis and coagulation. Sepsis 1999, 3, 85.
19. Levi, M.D; Cate, H. Disseminated Intravascular Coagulation. N. Engl. J. Med. 1999, 34, 586-592.
20. Cavaillon, J.M.; Adib-Conquy, M.; Fitting, C.; Adrie, C; Payen, D. Cytokine cascade in sepsis. Scand. J. Infect. Dis. 2003, 35, 535-544.
21. Igonin, A.A.; Kukes, V.G.; Paltsev, M.A. Sepsis: Molecular mechanisms of systemic inflammation as a model for the study of promising therapeutic targets. Mol. Med. 2004, 2, 3-12.
22. Pernerstorfer, T.; Hollenstein, U.; Hansen, J.; Stohlawetz, P.; Eichler, H.-G.; Handler, S.; Speiser, W.; Jilma, B. Lepirudin blunts endotoxin-induced coagulation activation. Blood 2000, 95, 1729-1734.
23. Levi, M.; Dorffler-Melly, J.; Reitsma, P.; Buller, H.; Florquin, S.; van der Poll, T.; Carmeliet, P. Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. Blood 2003, 101, 4823-4827.
24. Pawlinski, R.; Pedersen, B.; Schabbauer, G.; Tencati, M.; Holscher, T., Boisvert,W.; Andrade-Gordon, P.; Frank, R.D.; Mackman, N. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 2004, 103, 1342-1347.
25. Levi, M.; Poll, T.; Cate, H.; Deventer, S.J. The cytokine mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur. J. Clin. Investig. 1997, 27, 3-9.
26. Kerr, R.; Stirling, D.; Ludlam, C.A. Interleukin-6 and haemostasis. Br. J. Haematol. 2001, 115, 3-12.
27. Schiffer, E.R.; Reber, G.; De Moerloose, P.; Morel, D.R. Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model. Crit. Care Med. 2002, 30, 2689-2699.
28. Li, Y.; Sun, J.-F.; Cui, X.; Mani, H.; Danner, R. L.; Li, X.; Su, J.-W.; Fitz, Y.; Eichacker, P.Q. The effect of heparin administration in animal models of sepsis: A prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies. Crit. Care Med. 2011, 39, 1104-1112.
29. Thomas, W.S. Coagulation Activation by Lipopolysaccharides. Clin. Appl. Thromb Hemost. 2009, 15, 209-219.
30. Doǧanyiǧit, Z.; Küp, F.Ö.; Silici, S.; Deniz, K.; Yakan, B.; Atayoglu, T. Protective effects of propolis on female rats histopathological, biochemical and genotoxic changes during LPS induced endotoxemia. Phytomedicine 2013, 20, 632-639.
31. Gouda, K.H. Thymoquinone supplementation ameliorates acute endotoxemia-induced liver dysfunction in rats. Pak. J. Pharm. Sci. 2010, 23, 131-137.
32. Zager, R.A.; Johnson, A.C.; Lund, S.; Hanson, S.Y.; Abrass, C.K. Levosimendan protects against experimental endotoxemic acute renal failure. Am. J. Physiol. Renal Physiol. 2006, 290, 1453-1462.
33. Zvyagintseva, T.N.; Shevchenko, N.M.; Popivnich, I.B.; Svetasheva, T.G.; Isakov, V.V.; Skobun, A.S.; Elyakova, L.A. Procedure for the Separation of Water-Soluble Polysaccharides from Brown Seaweeds. Russian Patent 2135518, 27 August 1999.
34. Westphal, O.; Jann, K. Bacterial Lipopolysaccharides. Extraction with Phenol-Water and Further Applications of the Procedures. In Methods in Carbohydrate Chemistry; Whistler, B.L., Wolfrom, M.L., Eds.; Academic Press: New York, NY, USA, 1965; Volume 9, pp. 83-91.